Netflix has described the production lessons behind bringing LLM inference into its internal serving platform, including the ...

Artificial intelligence is expensive to use, many companies discovered. That has led to a new era of saving costs. Credit...Andrea Chronopoulos Supported by By Eli Tan Reporting from San Francisco ...

If you hang out in any even vaguely AI-skeptical parts of the Internet, you’ve probably stumbled on plenty of memes and posts premised on data centers’ insatiable thirst for water to power evaporative ...

Just about half of individuals 55 and older said they do not plan on using artificial intelligence, but many of those who have embraced the technology say they’ve had positive personal results. Almost ...

Ask a roomful of senior executives what AI can do for their business, and the answers will probably cluster around the same themes: lower costs, smaller headcount, faster processes, leaner operations.

In a world where AI can generate research papers, solve equations or create art, educators worry about how college students may be using it, misusing it or missing out on it. Yet there have been few ...

OpenEvidence, an AI-powered medical search tool, has become a fast friend to America’s doctors and is now used by nearly two-thirds of physicians. Your doctor is probably using AI, even if they ...

The website for the popular JDownloader download manager was compromised earlier this week to distribute malicious Windows and Linux installers, with the Windows payload found deploying a Python-based ...

It’s been almost three years since Silicon Valley started aggressively pushing large language model-based chatbots like ChatGPT as the supposedly inevitable future of everything, and there’s no group ...

Despite the lingering perception that no one really uses Copilot, Microsoft said Wednesday that its user base and engagement are growing for the AI tool that’s baked into M365 apps like Word, Excel, ...

Millions of Americans are turning to AI chatbots for health answers. Doctors are, too. But the ways doctors are incorporating AI chatbots into their practice are surprising. Specialized medical AI ...

News is breaking today that Replimune Group, Inc.'s (REPL) Biologics License Application ("BLA") requesting approval for its drug candidate RP1 (vusolimogene oderparepvec) in the indication of anti-PD ...